Skip to main content
ACS AuthorChoice logoLink to ACS AuthorChoice
. 2022 Feb 23;85(3):647–656. doi: 10.1021/acs.jnatprod.1c01211

Cytotoxic Sesquiterpenoids from Ammoides atlantica Aerial Parts

Sihem Boudermine †,, Valentina Parisi §, Redouane Lemoui , Tarek Boudiar , Maria Giovanna Chini , Silvia Franceschelli §, Michela Pecoraro §, Maria Pascale §, Giuseppe Bifulco §, Alessandra Braca ¶,, Nunziatina De Tommasi §,*, Marinella De Leo ¶,
PMCID: PMC8961869  PMID: 35196017

Abstract

graphic file with name np1c01211_0004.jpg

Seven new terpenoids, namely, guaiane (14), eudesmane (5), and bisabolane (6) sesquiterpenoids and a furanone (7), were isolated from the aerial parts of Ammoides atlantica, a herbaceous plant growing in Algeria, together with eight known compounds. All metabolites were characterized by their 1D and 2D NMR and HRESIMS data. A combined DFT/NMR method was applied to study the relative configurations of 14, 6, and 7. All compounds, except 2, were assayed against MCF-7, A375, A549, HaCaT, and Jurkat cell lines. Compounds 8, 10, and 11 induced a dose-dependent reduction in cell viability with different potency on almost all cell lines used. The most active compounds, 8 and 10, were studied to assess their potential apoptotic effects and cell cycle inhibition.


In Algeria, the plant family Apiaceae consists of about 55 genera and 130 species. Among them, the genus Ammoides is represented only by two species, of which one, A. atlantica (Coss & Durieu) H. Wolff, is an endemic plant1 traditionally used as an infusion to treat headache, fever, diarrhea, and vitiligo2 and is also added as a spice in some recipes.

Flavonoids and terpenoids are indicated in the literature as typical components of the genus Ammoides.3,4 However, previous chemical investigations of the plant were mainly focused on the analysis of the essential oil composition57 and on the polar extract antioxidant8 and anti-inflammatory9 activities and phytochemical characterization,10 while no studies have been reported to date on the separation and chemical identification of the nonpolar constituents.

In the course of continuing studies on Algerian species11,12 aimed at the isolation of cytotoxic and/or antiangiogenic specialized metabolites, a phytochemical study of the aerial parts of the A. atlantica chloroform extract, guided by an analytical approach based on UHPLC-HRESI-Orbitrap/MS, was performed, leading to the isolation and structural characterization of seven new terpenoids, namely, four guaiane (14), an eudesmane (5), and a bisabolane (6) sesquiterpenoid and a furanone (7), together with eight known compounds belonging to the sesquiterpene and flavonoid classes. The relative stereostructures of some of these secondary metabolites, namely, 14, 6, and 7, were assessed through a previously developed and optimized combined computational protocol (DFT/NMR),13,14 based on a comparison of the experimental 13C/1H NMR chemical shift data and the respective predicted values. A quantitative analysis of the main constituents of the cytotoxic chloroform extract was also carried out by means of LC-ESI/Orbitrap/MS.

Finally, all compounds were assayed against MCF-7 (human breast cancer), A375 (human malignant melanoma), A549 (human alveolar adenocarcinoma), Jurkat (human T-lymphocyte), and HaCaT (human epidermal keratinocyte) cell lines. The effect on apoptosis and cell cycle was also investigated for the two most active compounds found (8 and 10).

Results and Discussion

The aerial parts of A. atlantica were extracted with solvents of increasing polarity. The chloroform extract was investigated using a UHPLC-HRESI-Orbitrap/MS approach, indicating the presence of a series of sesquiterpenoids and polymethylated flavonoids previously unreported for this species. Thus, the extract was subjected to flash chromatography followed by RP-HPLC, to yield seven new (17) and eight known compounds (815) (Chart 1).

Chart 1.

Chart 1

The molecular formula, C17H22O8, of compound 1 was determined from the sodiated molecular ion at m/z 377.1204 [M + Na]+ in its HRESIMS, requiring seven indices of hydrogen deficiency. The 1H NMR spectrum (Table 1) showed the presence of three tertiary methyl groups at δH 1.36, 1.38, and 2.14, of which one was attributed to an acetyl methyl. The 13C NMR spectrum (Table 1) exhibited signals attributable to two methyls, one methylene, an olefinic methylene, two methines, four hydroxymethines, an olefinic quaternary carbon, three oxygenated tertiary carbons, an acetyl group, and a lactone moiety. 1D TOCSY and COSY experiments established the spin systems H-2–H-3, H-5–H2-9, and H2-9–H2-13 included in an α-methylene-γ-lactone typical of guaianolides15 and suggested the presence of two oxygenated methines at C-2 and C-9. The presence of an epoxy ring was suggested by the methine signal, at δC 61.6 and δH 3.62 (1H, d, J = 3.0 Hz), and the resonance at δC 72.0 in the 13C NMR spectrum. An HSQC experiment was used to correlate all protons to the respective carbons, thereby confirming all the above assignments. The HMBC spectrum showed correlations between the methyl signal at δ 1.36 and C-2 and C-4, the methyl signal at δH 1.38 and C-1 and C-9, the methine at δH 2.39 and C-4, C-7, and C-10, the hydroxymethine at δH 5.11 and C-7 and C-10, the methylene at δH 5.60 and 6.16 and C-7, C-11, and C-12, the hydroxymethine at δH 4.61 and C-1, C-5, and C-8, and the hydroxymethine at δH 3.62 and C-1 and C-5 and aided in the location of the hydroxy groups at C-1, C-2, C-9, and C-10 and the epoxy ring at C-3 and C-4. An acetyl group at C-9 was inferred from the HMBC correlation between δH 5.11 (H-9) and δC 169.9 (CH3CO). The relative configuration of compound 1 was studied by experimental NOE analysis and a DFT/NMR computational method. Diagnostic NOE correlations were observed between H-2 and H-3, H-2 and Me-14, H-5 and Me-14, and H-9 and Me-14, showing that these protons were cofacial. To support the correct stereostructure, a density functional theory (DFT)/NMR computational procedure was applied,13,14 following four principal phases: (1) conformational sampling performed at the empirical theory level, through molecular dynamics (MD) and/or by Monte Carlo multiple minimum methods (MCMM) for each diastereoisomer under examination; (2) optimization of the geometry and energy at the quantum mechanical (QM) level; (3) single-point GIAO calculations at the QM level of 13C/1H NMR chemical shift parameters of all the structures; and (4) comparison of the Boltzmann-averaged NMR properties calculated for each stereoisomer with those experimentally measured for the compound under examination using the mean absolute error (MAE) as a statistical parameter to indicate the most probable stereoisomer. MCMM and MD simulations were performed to account for an extensive conformational search at the empirical level for each of the 16 possible diastereoisomers of 1, using the OPLS force field (MacroModel, Schrödinger Suite 2021).16 In steps 2 and 3, the single-point GIAO calculations of 13C and 1H chemical shifts were performed on the nonredundant conformers using a MPW1PW91 functional and the 6-31G(d,p) basis set with IEFPCM for simulating the methanol solvent,17,18 for which the geometries were optimized previously at the same functional and 6-31G(d) basis set.19 Afterward, a comparison between the calculated and experimental 13C and 1H NMR chemical shifts for each diastereoisomer was evaluated by the Δδ parameter (Δδ = |δcalc – δexp|, the difference between experimental and calculated 13C and 1H NMR chemical shifts) and the MAE parameter [MAE = ∑[|δexp–δcalc|]/n, the summation (∑) of the n computed absolute δ error values (Δδ), normalized to the number of Δδ errors considered (n)]. Compound 1p showed the lowest 13C and 1H MAE values (3.0 and 0.11 ppm, respectively), indicating 1S*,2S*,3R*,4S*,9S*,10S* as the relative configuration for 1. The analysis of the MAE value was combined with the experimental NOE data reported above. To confirm the findings obtained, the DP4+ method,20,21 a powerful tool for assigning the correct stereochemical patterns of organic compounds, was also employed, and the isomer 1p showed the highest DP4+ probabilities (100.00%). Thus, the structure established for 1 was 1S*,2S*,10S*-trihydroxy-3R*,4S*-epoxy-9S*-acetoxy-5α,7αH-guaia-11(13)-en-12,6α-olide.

Table 1. 1H and 13C NMR Spectroscopic Data of Compounds 13a.

  1
2
3
position δH δC δH δC δH δC
1   86.7   93.5   134.8
2 3.69 br s 78.1 5.85 d (6.0) 140.0   195.2
3 3.62 d (3.0) 61.6 5.90 d (6.0) 134.3 6.20 s 135.0
4   72.0   82.7   173.0
5 2.39 d (11.0) 56.6 2.72 d (11.0) 67.2 3.69 d (10.4) 52.3
6 4.61 dd (11.0, 10.0) 79.6 4.57 dd (11.0, 10.0) 83.0 3.86 br t (10.5) 79.2
7 3.15 m 42.9 3.39 m 39.1 2.56 br dd (11.5, 10.4) 59.0
8a 2.43 m 30.3 2.34 m 34.5 4.87b 71.7
8b 1.85 m   1.93 m      
9a 5.11 dd (5.0, 2.0) 80.0 3.99 br t (3.0) 80.6 2.89 dd (13.2, 11.0) 44.6
9b         2.43b  
10   71.9   77.0   147.5
11   139.0   140.8 2.68 m 41.1
12   170.1   172.1   179.0
13a 6.16 d (2.0) 119.0 6.22 d (2.5) 120.3 1.39 d (6.5) 15.9
13b 5.60 d (2.0)   5.68 d (2.5)      
14 1.38 s 22.7 1.02 s 22.8 2.44 s 20.9
15 1.36 s 22.9 1.42 s 22.0 2.36 s 20.9
CH3CO 2.14 s 20.0     2.13 s 20.0
CH3CO   169.9       171.0
a

Spectra were recorded in methanol-d4 at 600 MHz; J values are in parentheses and reported in Hz; chemical shifts are given in ppm; assignments were confirmed by COSY, 1D-TOCSY, HSQC, and HMBC experiments.

b

Overlapped signal.

Compound 2 (C15H20O6) displayed a sodiated molecular ion at m/z 319.1155 [M + Na]+, requiring six hydrogen deficiencies. Its NMR features suggested the presence of a guaianolide sesquiterpene.15,22 The NMR spectra (Table 2) showed the presence of two methyls, two methylenes (one olefinic), four methines (two olefinic), two hydroxymethines, three oxygenated tertiary carbons, one quaternary carbon, and a lactone group. 1D TOCSY, COSY, and HSQC experiments were useful to establish the spin systems, H-5–H-9 and H-6–H2-13, included in an α-methylene-γ-lactone unit. The HMBC spectrum showed correlations between the methyl signal at δH 1.02 and C-1 and C-9, the methyl signal at δH 1.42 and C-2, C-4, and C-5, the methine at δH 2.72 and C-1, C-4, C-6, and C-10, the hydroxymethine at δH 4.57 and C-8, and the olefinic methines at δH 5.85 and 5.90 and C-1, C-4, and C-5, hence locating the double bond at C-2,C-3 and the hydroxy groups at C-1, C-4, and C-9. Following the same computational protocol described above, also, in this case, the DFT/NMR protocol13,14 was used to suggest the relative configuration of this secondary metabolite; thus, 2i showed the lowest 13C and 1H MAE values (2.10 and 0.12 ppm, respectively), indicating 1S*,4R*,9R*,10R* as the relative configuration for 2. To confirm these findings, the DP4+ method, where the isomer 2i showed the highest DP4+ probabilities (100.00%), was also employed. Thus, the structure established for 2 was 1S*,4R*,9R*,10R*-tetrahydroxy-5α,7αH-guaia-2(3),11(13)-dien-12,6α-olide.

Table 2. 1H and 13C NMR Spectroscopic Data of Compounds 46a.

  4
5
6
position δH δC δH δC δH δC
1a   80.0 3.45 dd (12.0, 4.0) 76.0 1.72 m 31.1
1b         1.33 m  
2a 2.01b 29.0 2.15 m 40.7 3.96 m 67.0
2b 1.54b   1.57 dd (11.0, 2.0)      
3a 1.55b 28.7 4.00 dd (13.0, 6.0) 70.1   135.9
3b 1.23 m          
4 2.02b 36.0   146.1 5.52 br s 131.6
5   72.3 1.74 d (11.0) 53.7 3.89 d (9.5) 71.0
6a 2.44 d (14.0) 27.2 5.22 d (11.0) 79.6 1.75 m 42.1
6b 1.38 m          
7 1.69b 47.5   167.2 2.01 m 33.1
8a 1.70 m 30.2 3.08 br dd (14.0, 3.5) 23.9 1.41 m 33.6
8b 1.34 m   2.54 ddd (18.0, 14.0, 6.0)   1.24 m  
9a 2.01b 36.0 2.25 br dd (14.0, 5.0) 37.6 1.62 m 30.6
9b 1.53b   1.32 m      
10   75.2   40.0 4.03 br t (6.4) 78.3
11   74.7   121.1   147.6
12a 1.18 s 2657   174.2 4.94 br s 111.7
12b         4.83 br s  
13 1.14 s 25.3 4.31 s 53.5 1.74 s 18.3
14 1.28 s 24.5 0.93 s 10.6 0.85 d (6.5) 15.3
15a 1.05 d (6.2) 19.0 5.41 br s 106.2 1.81 s 20.9
15b     5.12 br s      
CH3CO     1.91 br s 23.0    
CH3CO       178.0    
a

Spectra were recorded in methanol-d4 at 600 MHz; J values are in parentheses and reported in Hz; chemical shifts are given in ppm; assignments were confirmed by COSY, 1D-TOCSY, HSQC, and HMBC experiments.

b

Overlapped signal.

The HRESIMS of compound 3 (m/z 321.1332 [M – H]) and the 13C NMR data were consistent with a molecular formula of C17H22O6. The 1H NMR spectrum (Table 1) showed signals for a methyl doublet at δH 1.39 (J = 6.5 Hz), two methyl singlets linked to double bonds at δH 2.36 and 2.44, a hydroxymethine broad triplet at δH 3.86 (J = 10.5 Hz), a singlet for an olefinic proton at δH 6.20, and an acetyl group at δH 2.13. The 13C NMR spectrum (Table 1) displayed signals typical of a guaiane-type sesquiterpene acid with an α,β-unsaturated carbonyl group at δC 135.7, 172.9, and 198.2, a double bond at δC 134.8 and 147.5, a carboxylic acid unit at δC 179.8, two oxygen-bearing carbon resonances at δC 71.7 and 82.2, and an acetyl group at δC 171.0 and 20.0. The α,β-unsaturated carbonyl was proposed at the C-2/C-4 positions by the HMBC correlation peaks between H-3–C-2, H-3–C-5, H-5–C-3, H-5–C-4, and H-5–C-6. The C-1,C-10 positions of the double bond were deduced from the HMBC correlations of Me-14–C-1, Me-14–C-9, and Me-14–C-10, while the HMBC correlations between H2-9–C-8 and H-7–C-8 were used to locate the acetoxy group at C-8. Finally, the HMBC correlations between H-5–C-6 and Me-15–C-6 led to the location of the hydroxy group at C-6. Considering this multistep analysis, a tentative stereoassignment was proposed for 3. Thus, the stereoisomer 3b among the eight possible diastereoisomers endowed with 7R*, 8R*,11S* configuration patterns with 13C NMR and 1H MAE values (3.48 and 0.16 ppm, respectively) was suggested. Also in this case, a NOESY correlation between H-6 and H-7 was used to support the hypothesis proposed. Also in this case, the DP4+ method was used to corroborate the configurational assignment mode, where the isomer 3b showed the highest DP4+ probabilities (99.880%). Therefore, compound 3 was elucidated as 2-oxo-6α-hydroxy-8R*-acetoxyguaia-1(10),3(4)-dien-12-oic acid.

Compound 4 gave a molecular formula of C15H26O3, according to the [M + Na]+ ion at m/z 277.1756 (calcd for 277.1774) in its HRESIMS, requiring three indices of hydrogen deficiency. Its 1H NMR spectrum (Table 2) showed the signals of three tertiary methyls (δH 1.14, 1.18, and 1.28) and one secondary methyl group (δH 1.05, d, J = 6.2 Hz). The 13C NMR experiment (Table 2) exhibited 15 carbon signals, attributable to four methyls, five methylenes, two methines, and four oxygenated tertiary carbons. A comparison between these carbon chemical shifts and those of compounds 13 and related guaianolides led to the conclusion that compound 4 possesses a guaianolide skeleton.23 A COSY experiment of 4 showed connectivities between H-2–Me-15 in ring A and between H-6–H-9 in ring B. The presence of an epoxy ring was supported by the signals at δC 81.0 (C-1) and 72.3 (C-5) in the 13C NMR spectrum. Moreover, two nonprotonated carbinol carbons (δC 75.0 and 74.7) were also observed in the 13C NMR spectrum.23 HMBC cross-peaks of Me-15 to C-3, C-4, and C-5, of H-6 to C-1, C-8, and C-11, of Me-12 and Me-13 to C-7 and C-11, and of Me-14 to C-1, C-9, and C-10 suggested that two hydroxy groups are linked to C-10 and C-11. The relative configuration of 4a (1R*,4R*,5R*,7R*,10R*) was suggested as a tentative stereoassigment of 4, on considering the 13C and 1H MAE values (2.44 and 0.19 ppm, respectively). Thus, 4 was characterized as 1R*,5R*-epoxy-guaian-10R*,11-diol.

Compound 5 was assigned a molecular formula of C17H24O7 by means of the HRESIMS (m/z 339.1440 [M – H]). The 1H NMR spectrum (Table 2) displayed resonances for one methyl singlet (δH 0.93), one hydroxymethylene (δH 4.31), three hydroxymethines (δH 3.45, 4.00, and 5.22), one exocyclic methylene (δH 5.12 and 5.41), and an acetyl group (δH 1.91). The 13C NMR spectrum (Table 2) indicated that 5 contains a methyl, four methylenes (one olefinic), a hydroxymethylene, a methine, three hydroxymethines, four quaternary carbons, an acetyl, and a carboxylic group. All these above-mentioned signals suggested a eudesmane framework for 5.24 Results obtained from 1D TOCSY and COSY experiments established the correlations of all protons showing the sequences H-1–H-3, H-5–H-6, and H-8–H-9. An HMBC experiment was helpful in defining the substituent locations; thus the exocyclic double bond was located at C-4,C-15 from the H2-15–C-3 and H2-15–C-5 correlations, the double bond was placed at C-7,C-11 through the H2-13–C-7 and H2-13–C-12 correlations, and the hydroxymethines were positioned at C-1, C-3, and C-6 as a result of the H-2–C-1, H-2–C-3, and H-5–C-6 correlations, respectively. The acetyl moiety was placed at C-6 as evidenced by the chemical shift of the H-6 signal (δH 5.22). The relative stereochemistry of compound 5 was proposed from the 1H NMR coupling constant values of H-1, H-3, H-5, and H-6 and compared with those reported for closely related eudesmanes in the literature.24 Consequently, compound 5 was proposed as 1β,3β,13-trihydroxy-6α-acetoxy-eudesma-4(15),7(11)-dien-12-oic acid.

The HRESIMS of 6 (molecular formula C15H26O3) gave a [M + Na]+ peak at m/z 277.1774. The 13C NMR spectrum (Table 2) confirmed the presence of 15 carbons that were sorted as three methyls, four methylenes (one olefinic), six methines (including three oxygenated and one olefinic), and two quaternary carbons. The 1H NMR spectrum showed signals for two methyl group singlets at δH 1.74 and 1.81, one methyl doublet at δH 0.85 (J = 6.5 Hz), one exocyclic methylene at δH 4.83 and 4.94, one sp2 proton broad singlet at δH 5.52, three oxygenated methines at δH 3.89, 3.96, and 4.03, and signals for methylenes and methines in the region between δH 1.20 and 2.10. Results obtained from the COSY spectrum established the proton correlations of compound 6, permitting the establishment of the spin systems H-1–H-2 and H-4–H-10, leading to the proposal of the presence of a bisabolene sesquiterpene.15,25 The HSQC and HMBC spectra also assisted in assigning most of the substituents: in particular, the methyl signal at δH 1.74, showing an HMBC correlation with the carbon signal at δC 78.3 (C-10), was used to locate a hydroxy group at C-10. The hydroxy group at C-2 was indicated by the HMBC correlation between H-4–C-2 and Me-15–C-2, while the hydroxy group at C-5 was deduced by the HMBC correlations between H-4–C-5. Following the same procedures reported above, diastereoisomer 6d (2S*,5R*,6R*,7S*,10S*) showed a better fit with the experimental data (2.14 and 0.11 ppm as 13C and 1H MAE values, respectively, and 100.00% as DP4+ probability value). Thus, compound 6 was assigned the proposed structure of 2S*,5R*,10S*-trihydroxybisabol-3,12-diene.

Compound 7 was assigned the molecular formula C10H16O4 (m/z 223.0942 [M + Na]+) by HRESIMS. Analysis of its 1D and 2D NMR spectra (see Experimental Section) revealed 7 to have three methyl singlets (δH 1.31 and 1.32), a methylene (δH 2.53, 2.69, d, J = 16.5 Hz), three methines (two olefinic) (δH 4.74, d, J = 8.0 Hz, 5.67, dd, J = 16.0, 8.0 Hz and 5.97, d, J = 16.0 Hz), two oxygenated tertiary carbons, and a lactone. All proton and carbon signals were accurately assigned by means of HSQC and HMBC experiments. In particular, the HMBC correlations between the methyl signal at δH 1.31 and C-2, C-3, and C-4 allowed the location of an oxygenated tertiary carbon at C-3, while the HMBC cross-peaks between the signal at δH 5.67 and C-4 and C-7 indicated the occurrence of a five-membered side chain linked at C-4 with a terminal oxygenated tertiary carbon. Finally, the HMBC correlations between δH 4.74 and C-1, C-3, and C-6 and δH 2.53 and 2.69 and C-1 supported the lactone being in a 2(3H)-furanone ring. Compound 7a showed the lowest 13C and 1H MAE values (1.17 and 0.08 ppm, respectively), indicating 3S*,4R* as the relative configuration for 7. To confirm these findings, the DP4+ method was also employed, where the isomer 7a showed the highest DP4+ probabilities (100.00%). In light of these data, the structure of 7 was elucidated as dihydro-3S*-hydroxy-3S*-methyl-4R*-(3-hydroxy-3-methyl-1-buten-1-yl)-2(3H)-furanone.

The remaining isolated compounds were characterized as the sesquiterpenes epi-tanaphilin (8),26seco-tanapartholide B (9),27 9α-acetoxyartecanin (10),15 apressin (11),28 3α-chloro-9α-acetoxy-4β,10α-dihydroxy-1β,2β-epoxy-5α,7αH-guai-11(13)-en-12,6α-olide (12),15 and 1β,3β-dihydroxy-13-acetoxy-eudesma-4(15),7(11)-dien-12,6α-olide (13)24 and the polymethylated flavonoids gossypetin 3,7,3′-trimethyl ether (14)29 and tanetin (15),30 by NMR and MS analysis and comparison of their data with those reported in the literature. Furthermore, the relative stereoassigment of seco-tanapartholide B (9) as 4S*,5R*,6R*,7R* (2.12 and 0.17 for 13C and 1H MAE values, respectively) was suggested.

The chemical profile of the chloroform extract from A. atlantica aerial parts was investigated by UHPLC-HRESI-Orbitrap/MS. In agreement with results obtained through the isolation process, the major components were represented by terpenoids (peaks 113). In addition, the two methoxylated flavonoid aglycones (peaks 14 and 15) were also detected in the last region of the chromatogram (Figure 1). All compounds were identified based on full MS and MS/MS data (Table S1, Supporting Information) and injection of isolates as reference standards. Several minor peaks (al) were identified tentatively since the molecules hypothesized were not isolated from the extract, but only detected by analytical investigation. Peak a showed a deprotonated molecular ion [M – H] at m/z 155.0345, for which the fragmentation generated an intense base ion peak at m/z 111.04, due to the loss of a carboxylic unit, suggesting a to be an organic acid. Peak c showed the same full HRESIMS profile of 1 with a deprotonated molecular ion at [M – H] at m/z 353.1243 and two adduct ions [M + Cl] and [M + HCOOH] at m/z 389.1011 and 399.1297, respectively, suggesting c as an isomer of 1. Full MS ([M – H] at m/z 227.1287) and MS/MS of peak d ([M – H – H2O] and ([M – H – 2H2O] at m/z 209.12 and 191.11, respectively) were in agreement with the structure of a dihydroxy-dodecadienoic acid. Peak e was identified as a hydroxy-decatrienoic acid, as deduced by the [M – H] at m/z 181.0866 and fragment ions at m/z 137.10 ([M – H – CO2]) and 119.09 ([M – H – CO2 – H2O]). Peak f could be proposed as an isomer of 10 and 11 based on the high similarity between their full and MS/MS spectra. The full MS of peak g showed adduct ions [M + Cl] and [M + HCOOH] at m/z 303.1369 and 313.1659, respectively, and a deprotonated molecular ion [M – H] at m/z 267.1603 that generated a fragment ion at m/z 249.15 due to the loss of a water molecule, suggesting the occurrence of a sesquiterpene with at least one hydroxy group. Similarly, peaks h and i showed the same adduct ions [M + Cl] and [M + HCOOH] at m/z 423.1663 and 413.1374, respectively, and a deprotonated molecular ion [M – H] at m/z 377.1607, while the fragmentation MS displayed some product ions in common with compounds 10 and 11 (m/z 231.10, 213.09, 195.08, 171.08, 143.05, 123.04, and 93.03), suggesting the occurrence of two further sesquiterpene isomers having two acetyl groups ([M – H – 60 – 60] at m/z 257.08). MS/MS experiments on peak k (deprotonated molecular ion [M – H] at m/z 329.0667) generated the loss of two methyl groups (product ions at m/z 314.04 and 299.02); thus it was annotated as a dimethylated flavonoid. Similarly, peak l showed a deprotonated molecular ion [M – H] at m/z 313.0719 and two product ions at m/z 298.05 and 283.02, indicating the presence of two methyl groups on a flavonoid skeleton. Finally, peak j showed a deprotonated molecular ion [M – H] at m/z 523.2339 and a complex fragmentation pathway leading to being proposed as a sesquiterpene dimer (hypothesized molecular formula C30H36O8).

Figure 1.

Figure 1

UHPLC-HRESIMS profile of the chloroform extract of A. atlantica aerial parts. Peak numbers correspond to those of Chart 1. a = carboxylic acid; b = unidentified; c = isomer of 1; d = dihydroxy-dodecadienoic acid; e = hydroxy-decatrienoic acid; f = isomer of 10 and 11; g = sesquiterpene; h, j = sesquiterpene isomers; k, l = methoxylated flavonoids; j = sesquiterpene dimer.

Despite the wide biological activity of sesquiterpenoids, the low specificity of the Michael-type addition reaction represents a limitation for the use of these classes of compounds as therapeutic agents, due to their toxicity. On the other hand, several sesquiterpenoids have demonstrated to interact specifically with different molecular targets and to possess properties for drug-like compounds. Thus, these molecules, despite the toxicity of several derivatives, could be good candidates for the development of antitumor, anti-inflammatory, and antimicrobial drugs.31 In light of the above considerations, four human tumor cell lines (MCF-7, A375, A549, and Jurkat) and nontumor HaCaT cells were used to evaluate the cytotoxic activity of compounds 1 and 313 (40, 20, 10, and 5 μM) using an MTT ([3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide]) assay. Compound 2 was not tested since it was isolated in too small an amount. The results indicated that compounds 8, 10, and 11 induced a significant dose-dependent reduction in cell viability on most of the cell lines, with A549, A375, and Jurkat being more susceptible to these tested compounds (Table 3). Based on the data obtained from the viability test, the potential apoptotic effect and the evaluation of the cell cycle distribution were investigated for the most active and abundant compounds 8 and 10, with the A549 and Jurkat tumor cell lines and the nontumorigenic HaCaT cell line. With A549 and HaCaT cells, both compounds caused a significant increase in hypodiploid nuclei, after 24 h of treatment. In HaCaT cells these two compounds induced cells accumulating in the G2 phase at 40 μM, probably due to the high toxicity at this concentration. In Jurkat cells, a major proliferative capacity of these cells was confirmed by an increase of cell cycle S phase for both compounds in a dose-dependent manner. In agreement with these results, compound treatment with all three cell lines induced a significant (p < 0.001) increase of apoptotic response in a dose-dependent manner, as depicted by the hypodiploid nuclei in Figure 2.

Table 3. IC50 (μM) of Compounds 1 and 313 Using the MTT Assaya.

compound Jurkat A549 A375 MCF-7 HaCaT
1 >10 >10 >10 >10 >10
3 >10 >10 >10 >10 >10
4 >10 >10 >10 >10 >10
5 >10 >10 >10 >10 >10
6 >10 >10 >10 >10 >10
7 >10 >10 >10 >10 >10
8 7.7 ± 0.45 8.9 ± 0.60 >10 >10 2.9 ± 0.57
9 >10 >10 >10 >10 >10
10 5.0 ± 0.59 >10 3.7 ± 0.47 9.6 ± 0.52 1.6 ± 0.21
11 4.7 ± 0.45 4.1 ± 0.11 >10 >10 1.7 ± 0.55
12 >10 >10 >10 >10 3.5 ± 0.27
13 >10 >10 >10 >10 >10
Spb 3.2 ± 0.93 9.1 ± 1.20 2.1 ± 0.90 6.3 ± 0.55 1.6 ± 0.60
a

Data are expressed as IC50 (μM) values indicating the concentration of each compound that inhibits cell growth by 50% as compared to control cells.

b

Sp: Staurosporin (0.2 μM) was used as a positive control.

Figure 2.

Figure 2

Hypodiploid nuclei and cell cycle analysis of DNA content, with propidium iodide staining, were evaluated by a flow cytometric assay on A549 (panel A), Jurkat (panel B), and HaCaT (panel C) cells treated, respectively, with compound 10 or 8 (both 40–20–10–5 μM) for 24 h. Staurosporine (Sp) at 0.2 μM was used as a positive control. Results are expressed as means ± SEM of three independent experiments each performed in triplicate. Data were analyzed by the nonparametric Mann–Whitney U test. *p < 0.05, **p < 0.005, and ***p < 0.01 vs nontreated cells.

Considering the potential activity demonstrated by compounds 8, 10, and 11, a quantitative LC-MS analysis of the main components isolated from the CHCl3 extract was performed, recording high-resolution MS/MS data in PRM mode, useful for the targeted substance quantification. The results obtained confirmed sesquiterpenes being the major plant specialized metabolites present (2.55 ± 0.21 g/100 g DW), followed by methylated flavonoids (0.62 ± 0.09 g/100 g DW, Table S2, Supporting Information). Furthermore, the most abundant constituents were represented by the sesquiterpenes 8, 9, 10, and 11, while tanetin (15) was the most abundant flavonoid.

The present investigation has provided detailed information about the chemical composition of the nonpolar extract of A. atlantica aerial parts, highlighting the presence of cytotoxic sesquiterpenoids and methylated flavonoids. These findings suggested that this plant could be considered as a potential source of bioactive compounds and could provide scientific data to obtain more safe traditional medicinal plant preparations.

Experimental Section

General Experimental Procedures

Optical rotations were measured on an Atago AP-300 digital polarimeter with a 1 dm microcell and a sodium lamp (589 nm). NMR data were recorded on a Bruker DRX-600 spectrometer (Bruker BioSpinGmBH, Rheinstetten, Germany) equipped with a Bruker 5 mm TCI Cryoprobe at 300 K. All 2D NMR spectra were acquired in methanol-d4, and standard pulse sequences and phase cycling were used for the TOCSY, COSY, NOESY, HSQC, and HMBC spectra obtained. Data were processed with Topspin 3.2 software. HRESIMS data were measured on a Q Exactive Plus mass spectrometer, using an Orbitrap-based FT-MS system, equipped with an ESI source (ThermoFisher Scientific Inc., Bremen, Germany). Column chromatography was performed over silica gel (70–220 mesh, Merck, Germany). RP-HPLC separations were carried out using a Shimadzu LC-8A series pumping system equipped with a Shimadzu RID-10A refractive index detector and a Shimadzu injector (Shimadzu Corporation, Japan) on a C18 μ-Bondapak column (30 × 7.8 mm, 10 μm, Waters, Milford, MA, USA) and a mobile phase consisting of a MeOH–H2O mixture at a flow rate of 2.0 mL/min. TLC separations were conducted using silica gel 60 F254 (0.20 mm thickness) plates (Merck, Germany) and Ce(SO4)2–H2SO4 as spray reagent (Sigma-Aldrich, Italy).

Plant Material

The aerial parts of A. atlantica were collected in March 2016, in the Jijel Region, Algeria. The plant was identified by Dr. Jijar Dibilaire, and a voucher specimen (131AAT/VAREBIOL/451) was deposited in the Herbarium of the Chemistry Department, University of Constantine 1, Algeria.

UHPLC-HRESI-Orbitrap/MS/MS Analysis

UHPLC-HRESIMS/MS was performed using a Vanquish Flex binary pump LC system coupled with a Q Exactive Plus MS, using a C18 Kinetex biphenyl column (100 × 2.1 mm, 2.6 μm, Phenomenex, Italy) provided with a Security Guard Ultra cartridge, eluting with formic acid in acetonitrile 0.1% v/v (solvent A) and formic acid in H2O 0.1% v/v (solvent B) and developing a solvent gradient from 5 to 55% A within 14 min, at a flow rate 0.5 mL/min. The column oven and autosampler temperatures were maintained at 35 and 4 °C, respectively. Full spectra (70 000 resolution, 220 ms maximum injection time) and data dependent-MS/MS (17 500 resolution, 60 ms maximum injection time) were acquired in the negative-ionization mode in a scan range of m/z 120–1200 using ionization parameters as previously reported.32

Extraction and Isolation

The dried aerial parts of A. atlantica (120 g) were extracted with solvents of increasing polarity, including n-hexane, CHCl3, and MeOH, by exhaustive maceration (1 L), to give 1.5, 5.4, and 9 g of the respective dried residue. Part of the CHCl3 extract (4.6 g) was subjected to column chromatography (5 × 180 cm, collection volume 25 mL) over silica gel, eluting with n-hexane followed by increasing concentrations of CHCl3 in n-hexane (between 1% and 100%) continuing with CHCl3 followed by increasing concentrations of MeOH in CHCl3 (between 1% and 100%) and gathering 12 major fractions (A–L), together with pure compound 14 (7.0 mg). Fraction D (552.0 mg) was purified by RP HPLC with MeOH–H2O (47:53) as eluent to give compounds 11 (1.5 mg, tR 12 min), 4 (1.5 mg, tR 23 min), 3 (3.0 mg, tR 24 min), and 15 (10.9 mg, tR 52 min). Fraction E (147.0 mg) was submitted to RP-HPLC with MeOH–H2O (2:3) as eluent to yield compound 6 (1.2 mg, tR 48 min). Fraction F (290 mg) was separated by RP-HPLC eluting with MeOH–H2O (35:65) to give 10 (3.9 mg, tR 28 min) and 12 (1.9 mg, tR 56 min). Fraction G (390 mg) was separated by RP-HPLC eluting with MeOH–H2O (3:7) to give compounds 1 (4.2 mg, tR 10 min), 8 (3.8 mg, tR 18.0 min), 9 (3.0 mg, tR 19 min), and 10 (10.1 mg, tR 35 min). Fractions I (144.5 mg), J (218.0 mg), K (160 mg), and L (207 mg) were separately subjected to RP-HPLC eluting with MeOH–H2O (1:4) to give 8 (2.0 mg, tR 48 min) from fraction I, 1 (3.3 mg, tR 29 min) and 2 (0.8 mg, tR 40 min) from fraction J, 7 (1.7 mg, tR 28 min), 1 (0.3 mg, tR 30 min), and 8 (3.3 mg, tR 44 min) from fraction K, and 5 (1.2 mg, tR 13 min), 8 (1.7 mg, tR 52 min), and 13 (1.7 mg, tR 100 min) from fraction L, respectively.

Compound 1:

amorphous powder; [α]25D +29 (c 0.03, MeOH); 1H and 13C NMR, see Table 1; HRESIMS m/z 377.1204 [M + Na]+ (calcd for C17H22O8Na, 377.1212).

Compound 2:

amorphous powder; [α]25D −5 (c 0.1, MeOH); 1H and 13C NMR, see Table 1; HRESIMS m/z 319.1155 [M + Na]+ (calcd for C15H20O6Na, 319.1158).

Compound 3:

amorphous powder; [α]25D +48 (c 0.06, MeOH); 1H and 13C NMR, see Table 1; HRESIMS m/z 321.1332 [M – H] (calcd for C17H21O6, 321.1338).

Compound 4:

amorphous powder; [α]25D +4 (c 0.1, MeOH); 1H and 13C NMR, see Table 2; HRESIMS m/z 277.1756 [M + Na]+ (calcd for C15H26O3Na, 277.1774).

Compound 5:

amorphous powder; [α]25D +30 (c 0.1, MeOH); 1H and 13C NMR, see Table 1; HRESIMS m/z 339.1440 [M – H] (calcd for C17H23O7, 339.1444).

Compound 6:

amorphous powder; [α]25D −20 (c 0.1, MeOH); 1H and 13C NMR, see Table 3; HRESIMS m/z 277.1774 [M + Na]+ (calcd for C15H26O3Na, 277.1780).

Compound 7:

amorphous powder; [α]25D −35 (c 0.1, MeOH); 1H NMR (CD3OD, 600 MHz) δH 1.31 (3H, s, Me-10), 1.32 (6H, s, Me-8 and Me-9), 2.53 (1H, d, J = 16.5 Hz, H-2b), 2.69 (1H, d, J = 16.5 Hz, H-2a), 4.74 (1H, d, J = 8.0 Hz, H-4), 5.67 (1H, dd, J = 16.0, 8.0 Hz, H-5), 5.97 (1H, d, J = 16.0 Hz, H-6); 13C NMR (CD3OD, 600 MHz) δC 23.0 (C-10), 29.9 (C-8 and C-9), 43.0 (C-2), 70.7 (C-7), 77.0 (C-3), 90.8 (C-4), 121.7 (C-5), 143.3(C-6), 177.3 (C-1); HRESIMS m/z 223.0942 [M + Na]+ (calcd for C10H16O4Na, 223.0946).

Computational Details and Determination of Relative Compound Configurations

Maestro and LigpPrep (Maestro, Schrödinger Suite 2021; LigpPrep, Schrödinger Suite 2021)33,34 were used for generating the starting 3D chemical structures of the possible relative diastereoisomers of compounds 14, 6, and 7 (Chart 1). As a first step, exhaustive conformational searches at the empirical MM level with the MCMM method (50 000 steps) and the LMCS method (50 000 steps) were performed in order to allow a full exploration of the conformational space.13,14 Furthermore, molecular dynamics simulations were performed at different temperatures (450, 600, 700, 750 K), with a time step of 2.0 fs, an equilibration time of 0.1 ns, and a simulation time of 10 ns. All the conformers obtained from the conformational searches were minimized using the OPLS (Optimized Potentials for Liquid Simulation) force field and the Polak–Ribier conjugate gradient algorithm. The “Redundant Conformer Elimination” module of Macromodel (MacroModel, Schrödinger Suite 2021)16 was used to select nonredundant conformers. All the above-mentioned QM calculations were performed using Gaussian 09 software.18 In detail, the obtained conformers were optimized at the QM level using the MPW1PW91 functional and the 6-31G(d) basis set19 in methanol (IEFPCM) to reproduce the effect of the experimental solvent. The selected conformers for the different diastereoisomers were accounted for in the subsequent computation of the 13C and 1H NMR chemical shifts, using the MPW1PW91 functional and the 6-31G(d,p) basis set. Final NMR parameter (chemical shift) values for each of the investigated diastereoisomers were built considering the influence of each conformer on the total Boltzmann distribution taking into account the relative energies. Final 13C and 1H NMR chemical shift sets of data for each of the diastereoisomers were extracted and computed considering the influence of each conformer on the total Boltzmann distribution considering the relative energies. Calibrations of calculated 13C and 1H NMR chemical shifts were performed following the multistandard approach (MSTD).35,36 Also, sp2 13C and 1H NMR chemical shifts were computed using benzene as a reference compound, while TMS was used for computing sp3 13C and 1H chemical shift data. Experimental and calculated 13C and 1H NMR chemical shifts were compared by computing the Δδ parameter: Δδ = |δexp – δcalc|, where δexp (ppm) and δcalc (ppm) are the 13C/1H experimental and calculated chemical shifts, respectively. The MAEs for all the considered diastereoisomers were computed using the following equation: Inline graphic defined as the summation (∑) of the n computed absolute error values (Δδ), normalized to the number of chemical shifts considered (n). Furthermore, DP4+ probabilities related to all the stereoisomers for each compound were computed by considering both 1H and 13C NMR chemical shifts and comparing them with the related experimental data.

Quantitative Analysis

For the quantitative analysis of the main components, the most abundant isolated compounds were used for constructing calibration curves. Compounds 8, 11, and 14 were used as external standards for quantification of the seco-tanapartholides (8 and 9), the acetylated sesquiterpenoids (1, 3, 1012), and the methoxylated flavonoids (14 and 15), respectively. Stock acetonitrile solutions (1 mg/mL) were prepared and successive solutions at different concentrations were obtained in triplicate by serial dilution. Calibration curves were constructed using concentration (range 0.50–0.015 mg/mL) with respect to the areas obtained by integration of MS peaks operating in the parallel reaction monitoring (PRM) mode (17 500 resolution, normalized collision energy 50%, maximum injection time 65 ms). Linear simple correlation was considered to analyze the relation between variables (R2 = 0.9946 for 8; R2 = 0.9982 for 11, and 0.9716 for 14). Microsoft Office Excel was used to obtain the amount, finally expressed as g/100 g ± standard deviation (SD) of dry weight (DW).

Cell Culture

Breast cancer (MCF-7), malignant melanoma (A375), alveolar adenocarcinoma (A549), and epidermal keratinocyte (HaCaT) human cell lines were cultured in Dulbecco’s modified Eagle’s medium containing 10% fetal bovine serum (FBS), supplemented with 100 U/mL each of penicillin and streptomycin and 2 mM l-glutamine and grown at 37 °C under a 5% CO2 air humidified atmosphere. The leukemia cell line (Jurkat) was maintained in RPMI medium supplemented with 10% FBS, 2 mM l-glutamine, 100 U/mL penicillin, and 100 mg/mL streptomycin at 37 °C in 5% CO2.

Cell Viability

Cell viability was evaluated using a colorimetric assay based on an MTT assay, in order to compare the effect of potentially cytotoxic substances with a control. Briefly, cells were plated in 96-well tissue culture plates (3.5 × 103 cells/well), and, after 24 h, the medium was replaced with a fresh one alone or containing serial dilutions of compounds 1 and 313 (40–20–10–5 μM), and the incubation was performed for 48 h. Staurosporine (0.2 μM) was used as the positive control. At the end of the treatment, 25 μL of MTT (5 mg/mL) was added to each well and the cells were incubated for an additional 3 h to allow the formation of a purple formazan precipitate; then, 100 μL of a solution containing 50% (v/v) N,N-dimethylformamide, and 20% (w/v) sodium decyl sulfate with an adjusted pH of 4.5 was added.37 The optical density (OD) of each well was measured with a microplate spectrophotometer (Multiskan Spectrum Thermo Electron Corporation reader) equipped with a 620 nm filter. Cell vitality was calculated as % vitality = 100 × (ODtreated/ODDMSO).

Apoptosis and Cell Cycle Analysis

The effect of compounds 8 and 10 on cell death was analyzed by propidium iodide (PI) (Sigma-Aldrich) staining and flow cytometry. Cells were plated at a density of 3 × 104 cells/well in a 24-well plate. After 24 h, serial dilutions of compounds 8 and 10 (40–20–10–5 μM) were added and cells were recultured for 24 h. Staurosporine (0.2 μM) was used as a positive control. For apoptosis analysis cells were washed twice with phosphate-buffered saline (PBS) and incubated in 500 μL of a solution containing 0.1% Triton X-100, 0.1% sodium citrate, and 50 mg/mL PI, at 4 °C for 30 min in the dark. The PI-stained cells were subsequently analyzed by flow cytometry by FACS using CellQuest software. Data are expressed as the percentage of cells in the hypodiploid region. Cellular debris was excluded from the analysis by raising the forward scatter threshold, and the DNA content of the nuclei was registered on a logarithmic scale. Cell cycle profiles were evaluated by DNA staining with PI solution using a flow cytometer.38 Results from 10 000 events per sample were collected, and the relative percentage of the cells in G0/G1, S, and G2/M phases of the cell cycle was determined using the ModFit LT version 3.3 analysis software (BD Biosciences).

Data Analysis

Data are reported as mean ± SEM values of independent experiments, performed at least three times, with three or more independent observations. Statistical analysis was performed by the nonparametric Mann–Whitney U test. Differences with p < 0.05 were considered statistically significant.

Acknowledgments

The authors are thankful to “CISUP - Centro per l’Integrazione della Strumentazione Scientifica, Università di Pisa” for the instrumentation support. This work was also supported by a 2014 to 2020 POR CAMPANIA FESR grant from the Regional Council of the Campania Region, “Campania OncoTerapie - Combattere la Resistanza Tumorale: Piattaforma Integrate Multidisciplinare per un Approccio Tecnologico Innovativo alle Oncoterapie”.

Supporting Information Available

The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.jnatprod.1c01211.

  • HRESIMS and NMR spectra of compounds 17, UHPLC-HRESIMS data of the chloroform extract components, quantitative amounts of constituents isolated, and experimental and calculated NMR data of compounds 1, 2, 6, and 7 (PDF)

Author Contributions

# S.B. and V.P. contributed equally to this work.

The authors declare no competing financial interest.

Dedication

Dedicated to Dr. William H. Gerwick, University of California at San Diego, for his pioneering work on bioactive natural products.

Supplementary Material

np1c01211_si_002.pdf (2.3MB, pdf)

References

  1. Quezel P.; Santa S.. Nouvelle Flore de l’Algerie et des Regions Desertiques Meridionales; Centre National de la Recherche Scientifique: Paris, 1962; p 671. [Google Scholar]
  2. Loucif K.; Benabdallah H.; Benchikh F.; Mehlous S.; Kaoudoune C.; Bensouici C.; Amira S. J. Drug Delivery Ther. 2020, 10, 108–111. 10.22270/jddt.v10i4-s.4245. [DOI] [Google Scholar]
  3. Bousetla A.; Akkal S.; Medjroubi K.; Louaar S.; Azouzi S.; Djarri L.; Zaabat N.; Laouer H.; Chosson E.; Seguin E. Chem. Nat. Compd. 2005, 41, 95–96. 10.1007/s10600-005-0085-z. [DOI] [Google Scholar]
  4. Abdelli I.; Hassani F.; BekkelBrikci S.; Ghalem S. J. Biomol. Struct. Dyn. 2020, 39, 3263–3276. 10.1080/07391102.2020.1763199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Azar P. A.; Nekoei M.; Riahi S.; Ganjali M. R.; Zare K. J. Serb. Chem. Soc. 2011, 76, 891–902. 10.2298/JSC100219076A. [DOI] [Google Scholar]
  6. Laouer H.; Boulaacheb N.; Akkal S.; Singh G.; Marimuthu P.; de Heluani C.; Catalan C.; Baldovini N. J. Essent. OilRes. 2008, 20, 266–269. 10.1080/10412905.2008.9700008. [DOI] [Google Scholar]
  7. Boudiar T.; Bensouici C.; Safaei-Ghomi J.; Kabouche A.; Kabouche Z. J. Essent. OilBear. Plants 2011, 14, 172–174. 10.1080/0972060X.2011.10643918. [DOI] [Google Scholar]
  8. Benteldjoune M.; Boudiar T.; Bakhouche A.; del Mar Contreras M.; Lozano-Sanchez J.; Bensouici C.; Kabouche Z.; Segura-Carretero A. Nat. Prod. Res. 2021, 35, 1639–1643. 10.1080/14786419.2019.1619722. [DOI] [PubMed] [Google Scholar]
  9. El AbidineAbabsa Z.; Benkiki N.; Derouiche M. T.; Louaar S.; Medjroubi K.; Akkal S. Der Pharm. Lett. 2011, 3, 46–48. [Google Scholar]
  10. Louaar S.; Akkal S.; Bayet C.; Laouer H.; Guilet D. Chem. Nat. Compd. 2008, 44, 516–517. 10.1007/s10600-008-9110-3. [DOI] [Google Scholar]
  11. Beladjila K. A.; Berrehal D.; Kabouche Z.; Germanò M. P.; D’Angelo V.; De Tommasi N.; D’Andrea F.; Braca A.; De Leo M. J. Nat. Prod. 2019, 82, 510–519. 10.1021/acs.jnatprod.8b00893. [DOI] [PubMed] [Google Scholar]
  12. Iannuzzi A. M.; Muñoz Camero C.; D’Ambola M.; D’Angelo V.; Amira S.; Bader A.; Braca A.; De Tommasi N.; Germanò M. P. PlantaMed. 2019, 85, 1034–1039. 10.1055/a-0889-0412. [DOI] [PubMed] [Google Scholar]
  13. De Vita S.; Terracciano S.; Bruno I.; Chini M. G. Eur. J. Org. Chem. 2020, 2020, 6297–6317. 10.1002/ejoc.202000469. [DOI] [Google Scholar]
  14. Lauro G.; Bifulco G. Eur. J. Org. Chem. 2020, 2020, 3929–3941. 10.1002/ejoc.201901878. [DOI] [Google Scholar]
  15. Trifunović S.; Vajs V.; Juranić Z.; Žižak Z.; Tešević V.; Macura S.; Milosavljević S. Phytochemistry 2006, 67, 887–893. 10.1016/j.phytochem.2006.02.026. [DOI] [PubMed] [Google Scholar]
  16. Schrödinger Release 2021-4: MacroModel; Schrödinger, LLC: New York, 2021.
  17. Cancès E.; Mennucci B.; Tomasi J. J. Chem. Phys. 1997, 107, 3032–3041. 10.1063/1.474659. [DOI] [Google Scholar]
  18. Frisch M. J.; Trucks G. W.; Schlegel H. B.; Scuseria G. E.; Robb M. A.; Cheeseman J. R.; Scalmani G.; Barone V.; Mennucci B.; Petersson G. A.; Nakatsuji H.; Caricato M.; Li X.; Hratchian H. P.; Izmaylov A. F.; Bloino J.; Zheng G.; Sonnenberg J. L.; Hada M.; Ehara M.; Toyota K.; Fukuda R.; Hasegawa J.; Ishida M.; Nakajima T.; Honda Y.; Kitao O.; Nakai H.; Vreven T.; Montgomery J. J.A.; Peralta J. E.; Ogliaro F.; Bearpark M.; Heyd J. J.; Brothers E.; Kudin K. N.; Staroverov V. N.; Kobayashi R.; Normand J.; Raghavachari K.; Rendell A.; Burant J. C.; Iyengar S. S.; Tomasi J.; Cossi M.; Rega N.; Millam J. M.; Klene M.; Knox J. E.; Cross J. B.; Bakken V.; Adamo C.; Jaramillo J.; Gomperts R.; Stratmann R. E.; Yazyev O.; Austin A. J.; Cammi R.; Pomelli C.; Ochterski J. W.; Martin R. L.; Morokuma K.; Zakrzewski V. G.; Voth G. A.; Salvador P.; Dannenberg J. J.; Dapprich S.; Daniels A. D.; Farkas Ö.; Foresman J. B.; Ortiz J. V.; Cioslowski J.; Fox D. J.. Gaussian 09, Revision A.2; Gaussian, Inc.: Wallingford, CT, 2009.
  19. Cimino P.; Gomez-Paloma L.; Duca D.; Riccio R.; Bifulco G. Magn. Reson. Chem. 2004, 42, S26–33. 10.1002/mrc.1410. [DOI] [PubMed] [Google Scholar]
  20. Grimblat N.; Zanardi M. M.; Sarotti A. M. J. Org. Chem. 2015, 80, 12526–12534. 10.1021/acs.joc.5b02396. [DOI] [PubMed] [Google Scholar]
  21. Marcarino M. O.; Cicetti S.; Zanardi M. M.; Sarotti A. M. Nat. Prod. Rep. 2022, 39, 58–76. 10.1039/D1NP00030F. [DOI] [PubMed] [Google Scholar]
  22. Benteldjoune M.; Chini M. G.; Iannuzzi A. M.; Kabouche A.; Kabouche Z.; D’Ambola M.; Marzocco S.; Autore G.; Bifulco G.; De Tommasi N. PlantaMed. 2019, 85, 947–956. 10.1055/a-0941-0364. [DOI] [PubMed] [Google Scholar]
  23. Xie Z.-Q.; Ding L.-F.; Wang D.-S.; Nie W.; Liu J.-X.; Qin J.; Song L.-D.; Wu X.-D.; Zhao Q.-S. Chem. Biodiversity 2019, 16, e1900013 10.1002/cbdv.201900013. [DOI] [PubMed] [Google Scholar]
  24. Barrero A. F.; Herrador del Pino M. M.; GonzálezPortero A.; ArteagaBurón P.; Arteaga J. F.; BurilloAlquézar J.; Díaz C. E.; Coloma A. G. Phytochemistry 2013, 94, 192–197. 10.1016/j.phytochem.2013.04.002. [DOI] [PubMed] [Google Scholar]
  25. Barrero A. F.; Alvarez-Manzaneda R. E. J.; Alvarez-Manzaneda R. R. Phytochemistry 1990, 29, 3213–3216. 10.1016/0031-9422(90)80187-L. [DOI] [Google Scholar]
  26. Liu L.; Dai W.; Xiang C.; Chi J.; Zhang M. Molecules 2018, 23, 1639. 10.3390/molecules23071639. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Bohlmann F.; Zdero C. Phytochemistry 1982, 21, 2543–2549. 10.1016/0031-9422(82)85253-9. [DOI] [Google Scholar]
  28. Tsankova E.; Jacobsson Kempe U.; Norin T.; Ognyanov I. Phytochemistry 1981, 20, 1436–1438. 10.1016/0031-9422(81)80062-3. [DOI] [Google Scholar]
  29. Sakakibara M.; Timmermann B. N.; Nakatani N.; Waldrum H.; Mabry T. J. Phytochemistry 1975, 14, 849–851. 10.1016/0031-9422(75)83068-8. [DOI] [Google Scholar]
  30. Williams C. A.; Hoult J. R. S.; Harborne J. B.; Greenham J.; Eagles J. Phytochemistry 1995, 38, 267–270. 10.1016/0031-9422(94)00609-W. [DOI] [PubMed] [Google Scholar]
  31. Gonzalez-Padilla G. F.; Antunesdos Santos F.; Da Costa F. B. Crit. Rev. Plant Sci. 2016, 35, 1–20. 10.1080/07352689.2016.1145956. [DOI] [Google Scholar]
  32. Politi M.; Menghini L.; Conti B.; Bedini S.; Farina P.; Cioni P. L.; Braca A.; De Leo M. Molecules 2020, 25, 2225. 10.3390/molecules25092225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Schrödinger Release 2021-4: Maestro; Schrödinger, LLC: New York, 2021.
  34. Schrödinger, Release 2021-4: LigPrep; Schrödinger, LLC: New York, 2021.
  35. Sarotti A. M.; Pellegrinet S. C. J. Org. Chem. 2009, 74, 7254–7260. 10.1021/jo901234h. [DOI] [PubMed] [Google Scholar]
  36. Sarotti A. M.; Pellegrinet S. C. J. Org. Chem. 2012, 77, 6059–6065. 10.1021/jo3008447. [DOI] [PubMed] [Google Scholar]
  37. Pecoraro M.; Pinto A.; Popolo A. Toxicol. Vitro 2018, 47, 120–128. 10.1016/j.tiv.2017.11.004. [DOI] [PubMed] [Google Scholar]
  38. Franceschelli S.; Bruno A. P.; Festa M.; Falco A.; Gionti E.; d’Avenia M.; De Marco M.; Basile A.; Iorio V.; Marzullo L.; Rosati A.; Pascale M. Oxid. Med. Cell Longev. 2018, 2018, 5967890. 10.1155/2018/5967890. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

np1c01211_si_002.pdf (2.3MB, pdf)

Articles from Journal of Natural Products are provided here courtesy of American Chemical Society

RESOURCES